Drug manufacturing and formulation program (dmfp) task order #01: performance activity 1 technical support (1/15/15 / 1/14/16)

Ended Awarded Last action

Contract number
HHSN27100001
Awardee
Awarding agency
Obligated
$273,065

Award facts

Contract value 100% obligated
$273,064.87 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Albany, NY 12212, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00018 -$6,999
Funding Only Action P00017 · To administratively DE-obligate unexpended and expiring fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30,… -$2,614
Funding Only Action P00016 -$3,949
Exercise an Option P00015 · Drug manufacturing and formulation program (dmfp) $34,225
Funding Only Action P00014 · Curia global INC. - drug manufacturing and formulation program (dmfp) -$2,972
Exercise an Option P00013 · Drug manufacturing and formulation program (dmfp) $33,280
Funding Only Action P00012 -$3,011
Exercise an Option P00011 · Curia (formerly amri)- drug manufacturing and formulatiion program, to 1, exercise option no. 7 $32,364
Funding Only Action P00010 · Amri - drug manufacturing and formulatiion program -$4,244
Exercise an Option P00009 · Amri - drug manufacturing and formulatiion program, to 1, exercise option no. 6 $31,473
Funding Only Action P00008 -$1,589
Exercise an Option P00007 $30,608
Exercise an Option P00006 · Amri - exercise option no. 4 $29,769
Exercise an Option 5 $28,954
Exercise an Option 4 $28,163
Supplemental Agreement for work within scope 3 $4,576
Exercise an Option 2 $22,819
Supplemental Agreement for work within scope 1 $0
Original award $22,211
Show all 19

About this award

The National Institute on Drug Abuse issued a delivery order to Curia Global Inc. (doing business as Amri) on January 15, 2015, under the Drug Manufacturing and Formulation Program (DMFP) IDIQ, with a ceiling value of $273,064.87.

The DMFP is an IDIQ supporting pharmaceutical research and development services, including drug manufacturing and formulation activities. This delivery order covered Performance Activity 1 Technical Support from January 15, 2015 through January 14, 2016, with an ultimate completion date of January 14, 2025. Place of performance is Albany, NY.

The order used cost-plus-fixed-fee pricing with no set-aside. Government-invoiced labor shows a rising trend: FY2021 through FY2023 averaged $21 thousand annually at $72–$113 per hour with 0.1 FTEs; FY2024 escalated to $265 thousand invoiced at $133.26 per hour across 1.0 FTEs and 1,986 contractor hours. Curia Global self-performed all reported hours with no subcontractor engagement.

Quick answers

Who was awarded contract HHSN27100001?

HHSN27100001 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on January 15, 2015.

How much is contract HHSN27100001 worth?

The government has obligated $273,065 on HHSN27100001.

Is contract HHSN27100001 an order under another contract?

Yes. HHSN27100001 is a delivery order under HHSN271201500005I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).

Was contract HHSN27100001 competed?

The extent of competition for HHSN27100001 was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award